Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study
(2025)
Journal Article
Deneche, I., Couffignal, C., Mohammed, N. S., Højen, A. A., Font, C., Konstantinides, S., Kruip, M., Maiorana, L., Szmit, S., Abbel, D., Bertoletti, L., Cannegieter, S., Edwards, A., Edwards, M., Gava, A., Gussekloo, J., Johnson, M. J., Kumar, R., Langendoen, J., Lifford, K., …Mahé, I. (2025). Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study. Thrombosis Research, 19, Article 100209. https://doi.org/10.1016/j.tru.2025.100209
Introduction: To develop a European shared decision support tool (SDST), a Delphi process will be used to reach consensus about aspects relating to the continuation or deprescribing of antithrombotic therapy (ATT) in cancer patients at the end of lif... Read More about Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study.